CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home PIC/S and ANVISA Approval
News
10 Oct 2025

PIC/S and ANVISA Approval

Nabiqasim Pharma proudly announces the successful accreditation of its Injectable & Lyophilized Section by ANVISA and Hormonal Solid Dosage Manufacturing Section by PIC/S. 

Nabiqasim Pharma, a leading pharmaceutical manufacturer in Pakistan, proudly announces the successful accreditation of its Injectable & Lyophilized Section by ANVISA and Hormonal Solid Dosage Manufacturing Section by PIC/S. The company offers a diverse range of Branded Generic Formulations in Finished Dosage Forms (FDF) and provides Contract Manufacturing (CMO) services globally. It delivers high-quality formulations including Lyophilized Products, Prostaglandins, Creams, Ointments, Enemas, Tablets, Capsules, Syrups, and Infusions. Visit us at Stall No. 9.1A69, CPHI Frankfurt 2025.

Mentioned Companies
Nabiqasim Pharma Group
View company profile
Related categories
Injectables Finished Dosage Forms (Products) Lyophilisation Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services) Prostaglandins